Cancers

Hematological cancers (blood cancers)
Lung cancer
Breast cancer
Ovarian cancer
Neuroblastoma
Other solid tumor cancers

Cancer refers to a group of diseases characterized by an abnormal cell growth at the initial disease location that may spread to other locations in the body. Approximately 560,000 deaths in the United States were attributed to cancer in 2008.

Scientific evidence shows that one third of all cancers are related to lifestyle and environmental risk factors such as smoking, obesity, nutrition, infections, and exposure to toxins.

The use of stem cell therapy, in combination with classical therapeutic modalities such as surgery, chemotherapy and radiation, is currently being developed for the treatment of several types of cancers.

Blood stem cell transplantation is now considered a viable alternative for patients suffering from blood cancers, especially when a donor cannot be found for allogenous (from another person) bone marrow transplant.

Studies in China have shown positive results in various hematological diseases, and the survival rate of patients treated with their own peripheral blood stem cells was better than those who received the conventional therapies alone. This was especially evident for diseases such as non-Hodgkin lymphoma, acute myeloid leukemia and multiple myeloma. The conclusion of these studies is that our own peripheral blood stem cells collected through apheresis and injected back into the body after special treatment could improve the prognosis of malignant hematological diseases.

Similar results have been found in certain types of solid tumor cancers. Autologous peripheral stem cell transplantation appears to be a promising therapeutic modality for patients suffering from lung cancer, neuroblastoma (cancer of immature nerves that occurs in children), breast and ovarian cancer.

Cellulogix offers stem cell treatment for cancer with the collection of stem cells in peripheral blood through apheresis, a process that includes a reconditioning of cells and re-injection of the cells into the venous system.

Since behavioral and environmental factors play an important role in the development of cancer cells, cell therapy is combined with a holistic and comprehensive approach of the disease process. The entire treatment takes five days to complete and includes lifestyle and diet recommendations as well as personalized natural supplement prescriptions for overall health and immune system defense.

Follow-up and support is offered to all post stem cell treatment patients.

Industry News

Personal Letter From Dr. Nabavi

On Tuesday August 11, 2009 I suffered a heart attack. Fortunately, at the time of the attack, I was at the IBC clinic. I was hospitalized and my wonderful friends Dr. Rodriguez and staff went out of their way to help me.

Read More

Interview with European Health Magazine

During a recent visit to Europe Dr. Nabavi was interviewed by one of the European Health Magazines. The interview, conducted in December of 2008, was so thorough and comprehensive that we’ve decided to publish it; in it’s entirely. Read more about this insightful interview.

Read More

New Clinics on the Horizon

Cellulogix International is proud to announce that several clinics in Europe…

Read More

Opening Soon!

Cellulogix International will soon be operating from clinics in…

Read More